These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3925631)

  • 1. Inhibition of human T lymphocyte proliferation in vitro by commercial factor VIII concentrates.
    Wang Y; Beck EA; Furlan M; de Weck AL
    Vox Sang; 1985; 48(6):343-9. PubMed ID: 3925631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of interleukin-2 secretion by factor VIII concentrates: a possible cause of immunosuppression in haemophiliacs.
    Thorpe R; Dilger P; Dawson NJ; Barrowcliffe TW
    Br J Haematol; 1989 Mar; 71(3):387-91. PubMed ID: 2495017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors.
    Ceuppens JL; Vermylen J; Colaert J; Desmyter J; Gautama K; Stevens E; The AL; Vanham G; Vermylen C; Verstraete M
    Thromb Haemost; 1984 Apr; 51(2):207-11. PubMed ID: 6429883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some evidence for the in vivo functional activation of suppressor T cells in asymptomatic patients with hemophilia A receiving Factor VIII concentrates.
    Seki H; Taga K; Nagaoki T; Barot-Ciorbaru R; Miyawaki T; Taniguchi N
    Clin Immunol Immunopathol; 1985 Jan; 34(1):27-38. PubMed ID: 3155504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocytes from hemophiliacs proliferate after exposure to factor VIII product.
    Matheson DS; Green BJ; Poon MC; Bowen TJ; Fritzler MJ; Hoar DI
    Vox Sang; 1986; 51(2):92-5. PubMed ID: 2430365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors.
    Singer ST; Addiego JE; Reason DC; Lucas AH
    Thromb Haemost; 1996 Jul; 76(1):17-22. PubMed ID: 8819245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihemophilic factor [factor VIII] preparations inhibit lymphocyte proliferation and production of interleukin-2.
    Lederman MM; Saunders C; Toossi Z; Lemon N; Everson B; Ratnoff OD
    J Lab Clin Med; 1986 May; 107(5):471-8. PubMed ID: 3084691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII concentrates and the immune system--laboratory investigations.
    Wadhwa M; Barrowcliffe TW; Mire-Sluis AR; Thorpe R
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S65-79. PubMed ID: 7495973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo inhibition of monocyte phagocytic function by factor VIII concentrates: correlation with concentrate purity.
    Pasi KJ; Hill FG
    Br J Haematol; 1990 Sep; 76(1):88-93. PubMed ID: 2121266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of human T cell responses to allogeneic stimuli by factor VIII concentrates.
    Batchelor A; Steel CM; Ludlam CA
    Br J Haematol; 1992 Sep; 82(1):94-8. PubMed ID: 1419808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens.
    Köller U; Majdic O; Liszka K; Stockinger H; Pabinger-Fasching I; Lechner K; Knapp W
    Clin Exp Immunol; 1985 Mar; 59(3):613-21. PubMed ID: 3921299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intermediate-purity factor VIII (FVIII) concentrate on lymphocyte proliferation and apoptosis: transforming growth factor-beta is a significant immunomodulatory component of FVIII.
    Hodge G; Han P
    Br J Haematol; 2001 Nov; 115(2):376-81. PubMed ID: 11703339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?
    Froebel KS; Madhok R; Forbes CD; Lennie SE; Lowe GD; Sturrock RD
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1091-3. PubMed ID: 6226334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
    White GC; Greenwood R; Escobar M; Frelinger JA
    Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunologic evaluation of hemophiliac patients and their wives. Relationships to the acquired immunodeficiency syndrome.
    deShazo RD; Andes WA; Nordberg J; Newton J; Daul C; Bozelka B
    Ann Intern Med; 1983 Aug; 99(2):159-64. PubMed ID: 6603807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic abnormalities in patients with hemophilia A.
    Weintrub PS; Koerper MA; Addiego JE; Drew WL; Lennette ET; Miner R; Cowan MJ; Ammann AJ
    J Pediatr; 1983 Nov; 103(5):692-5. PubMed ID: 6415259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal T-cell subpopulations in hemophilic patients receiving factor VIII concentrates from voluntary donors.
    Wearne A; Joshua DE; Rickard KA; Kronenberg H
    Aust N Z J Med; 1984 Apr; 14(2):149-53. PubMed ID: 6236788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study.
    Goedert JJ; Cohen AR; Kessler CM; Eichinger S; Seremetis SV; Rabkin CS; Yellin FJ; Rosenberg PS; Aledort LM
    Lancet; 1994 Sep; 344(8925):791-2. PubMed ID: 7916077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.